MedPath

Applied study of Dhatwagni Siddhanta and find out the Difference between Kiratatiktadi Ghanavati and Tryushnadi Guggulu in Treatment of Dyslipidemia

Phase 3
Conditions
Health Condition 1: E788- Other disorders of lipoprotein metabolism
Registration Number
CTRI/2022/11/047542
Lead Sponsor
Mahatma Gandhi Ayurved College Hospital and Research Centre
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1 Patients willing for written informed consent to participate in the study

2 Newly diagnosed patient of the dyslipidemia Diagnosed within 1 year

3 Age between 20 to 60 years of either gender

4 Patient with controlled hypertension systolic not more than 140 mmHg and diastolic not more than 90 mmHg

5 Patient with controlled type 2 diabetes fasting below 130mgdl PP below 180 mgdl

6 Subjects fulfilling the following objective criteria of Dyslipidemia

Exclusion Criteria

1 Patients of age group below 20 yrs and above 60 yrs

2 Other systemic disorder Cardiovascular disorder Atherosclerosis and renal disorders etc

3 During pregnancy and lactation period in women

4 Chronic patients of Dyslipidemia

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To Assess the Efficacy of Kiratatiktadi Ghana Vati in Serum Total Cholesterol Serum Triglycerides Serum HDL Cholesterol Serum LDL Cholesterol <br/ ><br>Timepoint: 30 Days
Secondary Outcome Measures
NameTimeMethod
To Assess the Efficacy of kiratatiktadi ghanvati in Serum Total Cholesterol Serum Triglycerides Serum HDL Cholesterol Serum LDL CholesterolTimepoint: 0 day 15th day 30th day
© Copyright 2025. All Rights Reserved by MedPath